All compounds

A small molecule that blocks NNMT, the enzyme that drains NAD+ inside fat cells. Blocking it raises NAD+ and SAM, suppresses new fat creation and increases cellular energy expenditure without touching appetite. Injected under the skin each morning, 50 to 100 mg daily on a 4 to 6 week cycle.

An oral small molecule that blocks NNMT, the enzyme that drains nicotinamide away from NAD+ production in fat cells. Raising NAD+ lifts cellular energy expenditure, cutting fat mass while sparing muscle and without suppressing appetite; dosed 50 to 100 mg each morning in 4 to 6 week cycles.

A peptide supplied as a powder for subcutaneous injection, dosed once daily on an 8 to 12 week cycle. Little is documented beyond handling and dosing: what Adamax is, what it does, and who should avoid it have not been established.

The nasal spray form of Adamax, dispensing 100 mcg per spray at 1 to 6 sprays a day. Little is documented beyond handling and dosing: no effects, side effects, or exclusions have been established, and the correct cycle length is not known.

A chimeric peptide that destroys the blood vessels feeding white fat, so the fat cells die rather than simply shrink. Obese monkeys lost 7.4 to 14.7% of body weight over 28 days, but kidney toxicity appeared above 0.25 mg/kg and no human trial results have ever been published.

AICAR (acadesine) is a synthetic adenosine analogue that activates AMPK, the energy sensor exercise switches on. Animal data show endurance and mitochondrial gains; human IV trials show glucose uptake and cardiac protection. Practical subcutaneous protocols of 10 to 50 mg daily lack published dose-finding data.

A 16-amino-acid fragment of human growth hormone, engineered with a tyrosine substitution and developed as an anti-obesity drug. It pushes fat cells to release stored fat without raising IGF-1 or blood sugar. Safety data is strong; human fat-loss efficacy is weak. Reconstitute with 0.6% acetic acid.

A synthetic peptide derived from erythropoietin that keeps EPO's tissue-repair and anti-inflammatory signalling and drops its blood-thickening effects. Trial-tested for small-fibre neuropathy and nerve regeneration. Standard dose 4 mg daily for 28 days; users also run 2–4 mg daily, with an 8 mg short-course option.

A mitochondrial uncoupler taken as a single 50 mg pill each morning. Instead of letting cells store surplus fuel as fat, it lets mitochondria burn it off as heat — and unlike stimulant fat-burners, it is reported to do this without raising heart rate, blood pressure, or body temperature. Short cycles: 2 to 4 weeks on, 2 to 4 weeks off.

A 15-amino-acid peptide derived from a protective protein in human gastric juice, studied for repair of tendon, ligament, muscle, bone, gut lining and blood vessels. Reconstituted with bacteriostatic water and injected under the skin or into muscle near the injury; not FDA approved and banned in sport.

The capsule form of BPC-157, a peptide based on a protein found in stomach juice. Swallowed rather than injected, which suits gut-focused use. Studied for wound healing, inflammation, and repair of tendon, bone, and gut lining.

A three-peptide vial: 5 mg BPC-157, 5 mg TB-500, and 10 mg Cartalax, 20 mg in total. The standard repair pair with a cartilage-directed bioregulator added. Documentation for the blend covers dosing only; nothing has been established about the Cartalax component's role beyond its amount.

A swallowed pill containing 500 mcg of BPC-157 and 500 mcg of TB-500, the two most commonly paired repair peptides, in one dose. The mechanism, evidence, and timeline material comes from the injectable blend (the "Wolverine Stack"); the oral pill has no absorption data of its own, particularly for the TB-500 half.

A single vial holding BPC-157 and TB-500 together — 5 mg of each, 10 mg of peptide in total — injected once daily for 4 to 8 weeks. The best-known repair pairing in one shot: one arm concentrates near the injection site, the other distributes through the body.

A peptide bioregulator directed at the bronchopulmonary system — lung tissue, the bronchi, and respiratory function generally. Dosed six days a week at bedtime on a 40-day course, repeated after three to six months.

A long-acting amylin analogue (AM833) that switches on satiety through the brainstem, a pathway GLP-1 compounds do not touch. Half-life of 7 to 8 days, injected under the skin once weekly. In REDEFINE 1, cagrilintide with semaglutide produced 20.4% average weight loss over 68 weeks.

A peptide bioregulator for the heart and blood vessels, aimed at restoring normal protein production in heart muscle cells. Injected under the skin at bedtime on short 10 to 20 day courses, two or three times a year.

A tripeptide bioregulator (Ala-Glu-Asp) acting on fibroblasts and chondrocytes, studied in Russian cell-culture work for cartilage integrity, connective tissue resilience and cellular ageing markers. Injected under the skin at 2 mg daily on 10 to 20 day courses, three or four times a year.

Not a single peptide but a mixture: a neuroprotective peptide complex from pig brain tissue containing over 100 peptide fragments and nerve growth factor mimics. Studied for brain injury, stroke rehabilitation, dementia and neuropathy.

A 1:1 pairing of CJC-1295 No DAC with Ipamorelin, standard vial 10 mg total (5 mg of each), also sold as a 10/10 mg "Hulk" version. The two peptides hit separate arms of the growth hormone axis, so one injection gives a bigger pulse than either alone. Used for sleep, recovery, fat loss, and connective tissue.

A short-acting growth hormone releasing hormone analogue, also sold as Mod GRF (1-29), that produces sharp, natural-shaped GH pulses and clears in roughly 30 minutes. Used for sleep, recovery, fat loss, bone and connective tissue, usually paired with Ipamorelin and injected fasted under the skin.

CJC-1295 with DAC is a long-acting GHRH analogue that binds albumin to stay active for 5.8 to 8.1 days, raising growth hormone and IGF-1 with once or twice weekly subcutaneous dosing at 1 to 2 mg per week.

A thymus-derived bioregulator used to normalise immune function, support DNA repair, and maintain healthy gene expression in the immune system. Injected under the skin at bedtime for 20 days, three or four times a year.

An orally available angiotensin IV analogue studied in animals for Alzheimer's, Parkinson's, stroke and nerve damage, proposed to build new synapses by amplifying hepatocyte growth factor. No human studies exist. Users take 5 mg capsules, 5 to 20 mg daily, fasted in the morning, on 4 to 12 week cycles.

A single capsule combining Dihexa 5 mg, Methylene Blue 50 mg, and Tesofensine 500 mcg — a synapse-building nootropic, a mitochondrial electron carrier, and a triple reuptake inhibitor. One per day with a light meal. Methylene Blue blocks MAO-A, and Tesofensine must not be combined with MAO inhibitors; that conflict has not been resolved.

A naturally occurring nine-amino-acid peptide involved in sleep-wake regulation, studied for shortening the time it takes to fall asleep, lengthening total sleep and deepening slow-wave sleep. Reconstituted with bacteriostatic water and injected under the skin 30 to 60 minutes before bed.

The nasal spray form of the delta sleep-inducing peptide, supplied as 10 mg in a 10 mL atomizer giving 100 sprays of 100 mcg each. Taken 30 to 60 minutes before bed, with onset anywhere from 20 minutes to two hours.

A synthetic tetrapeptide modelled on the pineal polypeptide epithalamin, studied for reactivating telomerase, lengthening telomeres, and restoring melatonin production. Injected in the evening on short 10 to 20 day cycles repeated two to three times a year, at microgram doses far below the older milligram protocols.

A senolytic peptide that frees p53 from FOXO4 inside senescent cells so they undergo apoptosis. In practice dosed at 3 to 5 mg subcutaneously every other day for 3 doses, repeated 1 to 3 times per year; an older sheet ran 250 to 500 mcg daily over 8 to 16 weeks. Mouse data only, no completed human trials.

A copper-binding tripeptide the body already makes, with plasma levels falling from roughly 200 ng/mL at age 20 to about 80 ng/mL at 60. Studied for skin, hair, wound healing, nerve and tissue repair. Injected subcutaneously for systemic effects, or converted to a topical for skin.

The oral form of the copper peptide GHK-Cu. One dose a day for 8 to 12 weeks, then a 4-week break, preferably fasted. No oral strength, dose form, or human data is given anywhere; the compound's evidence comes from topical trials and injectable use, so read the injectable page for safety detail.

GHRP-2 (pralmorelin, KP-102) is a synthetic hexapeptide that binds the ghrelin receptor and drives short, strong pulses of the body's own growth hormone. Studied for appetite, lean mass, fat loss, recovery and sleep, and approved in Japan as a diagnostic agent. Injected under the skin.

The original growth hormone releasing peptide, developed in the 1980s. A six-amino-acid ghrelin mimic that drives strong GH pulses, suppresses somatostatin, and produces intense hunger. Also binds CD36, giving cardioprotective and wound-healing effects in animal models.

One 70 mg vial holding GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg: the Wolverine Stack plus a copper peptide. Aimed at tissue healing, skin ageing, hair growth, wound healing, and scar reduction. 5 to 10 units under the skin, daily for 4 to 6 weeks for healing or every other day for 8 to 16 weeks for skin.

A ready-mixed solution combining GHK-Cu with glutathione, histidine, glycine, and NADH — 402 mg of ingredients in every millilitre. Injected under the skin twice a week on a rising schedule, 25 units up to 100 units, over a 4 to 6 week cycle. A lower-dose, more frequent alternative is given for anyone who reacts to copper.

A GLP-1 receptor agonist that copies a gut hormone telling the brain the body is full, originally a type 2 diabetes medication now used mainly for weight loss. Mixed with bacteriostatic water and injected under the skin once weekly, titrating up to a 2.4 mg maintenance dose over roughly 16 to 17 weeks.

A 5 mg / 5 mg blend of a GLP-1 receptor agonist and a long-acting amylin analogue in one vial — 10 mg of peptide in total. The two work on different hormone pathways, and together they averaged 23–24.4% total body weight loss against 15–17% for the GLP-1 alone. Injected under the skin once a week.

GLP2-T (tirzepatide) is a once-weekly dual GLP-1 and GIP receptor agonist. SURMOUNT-1 recorded 15.0% to 22.5% average weight loss at 72 weeks, and it beat GLP1-S head to head, 20.2% against 13.7%. Mixed with bacteriostatic water and injected under the skin once a week.

GLP3-R (retatrutide) is a triple agonist at the GLP-1, GIP and glucagon receptors, given as one subcutaneous injection a week. Phase 2 produced 24.2% average weight loss at 48 weeks and Phase 3 28.7% at 68 weeks. Standard titration runs 2 mg to 12 mg weekly.

A single vial holding 12.5 mg of GLP3-R and 2.5 mg of Cagrilintide — 15 mg of peptide in total, at a fixed 1 mg to 200 mcg ratio. Intended only for people new to GLP3-R, because the potent amylin component forces a low starting dose. Injected under the skin once every seven days.

The body's master antioxidant, a tripeptide of three amino acids that clears free radicals, toxins and heavy metals and supports liver, skin, eye and immune health.

Gonadorelin is a synthetic copy of GnRH used alongside TRT to keep the pituitary releasing LH and FSH and so preserve testicular size and fertility potential. FDA approved only as a diagnostic (Factrel); its use as an HCG substitute rests on clinical practice rather than published trials.

A glycoprotein hormone that acts like luteinising hormone. In men it drives the testicles to make testosterone and sperm, preserving testicular size and fertility during TRT; in women it triggers ovulation in fertility treatment. Half-life about 24 to 36 hours; dosed in international units.

Hexarelin is the most potent peptide in the GHRP class, typically run at 100 to 200 mcg two to three times daily. It also raises cortisol and prolactin and desensitises the ghrelin receptor quickly, so 4 to 8 week cycles followed by 4 weeks off are treated as mandatory.

HGH 191aa (somatropin) is recombinant human growth hormone, identical to the pituitary hormone. Replacement doses of 1 to 2 IU daily improved body composition, skin thickness and bone density in trials; higher doses raise fluid retention, joint and blood glucose problems.

HMG (Human Menopausal Gonadotropin) supplies both FSH and LH activity in roughly a 1:1 ratio. It is added to an HCG protocol when sperm counts have not recovered after 4 to 6 months, typically at 75 to 150 IU three times weekly over 12 to 24 months.

Humanin is a 24-amino acid mitochondrial-derived peptide the body makes itself, studied in animals for neuroprotection, cardioprotection, insulin sensitivity and healthspan. No human trials exist; injectable protocols use the HNG analog at 500 mcg to 1 mg once or twice daily in 10 to 15 day cycles.

Hyaluronic acid is a water-binding glycosaminoglycan, not a peptide, found in skin, eyes and joint fluid. Oral doses of 100 to 200 mg daily improve skin hydration, elasticity and wrinkle depth in placebo-controlled trials, with results building over 8 to 12 weeks.

IGF-1 DES (des(1-3)IGF-1) is a 67-amino-acid form of IGF-1 that escapes binding proteins, making it roughly 10-fold more potent in cell culture, with a 20 to 30 minute half-life that suits targeted intramuscular use. No human clinical data exists for muscle growth.

A modified IGF-1 with roughly 3 times the potency of the native hormone and a 20 to 30 hour half-life. Builds muscle through both fibre enlargement and satellite cell activation. Dosed post-workout, reconstituted with 0.6% acetic acid rather than bacteriostatic water, and cycled 4 to 6 weeks on, 4 to 6 weeks off.

A four-part injectable blend of PE-22-28, Pinealon, NA-Semax, and Selank in a fixed 10:10:20:8 ratio, dosed once each morning on an 8-week cycle. Dosing is the only well-defined information available for the blend.

A selective pentapeptide growth hormone secretagogue that binds the ghrelin receptor and triggers a pulse of the body's own growth hormone without significantly raising ACTH, cortisol, or prolactin. Reconstituted with bacteriostatic water and injected under the skin, most often alongside CJC-1295 No DAC.

One vial holding 50 mg of GHK-Cu and 20 mg of KPV — a copper peptide for skin and tissue regeneration paired with a small anti-inflammatory peptide. Mixed with 3 mL of bacteriostatic water and injected under the skin at 4 units, then 8 units, once a day.

A brain-made neuropeptide at the top of the reproductive hormone chain, triggering GnRH and in turn luteinising hormone, follicle-stimulating hormone, and testosterone while leaving natural feedback intact. Studied for fertility, libido, metabolic function, and as a natural alternative to HCG.

An 80 mg four-peptide repair blend: GHK-Cu 50 mg, KPV 10 mg, BPC-157 10 mg and TB-500 10 mg in one vial. Aimed at inflammation control, gut integrity, tissue healing, collagen, blood vessel growth and skin and hair quality. KPV calms the copper injection reaction, but the copper is still the part to read about first.

A three-amino-acid fragment of alpha-MSH that suppresses NF-kB and MAP kinase signalling without touching melanocortin receptors, used against inflammation in the gut, skin, and joints, with antimicrobial activity.

KPV (oral) is the pill form of Lys-Pro-Val, a three-amino-acid anti-inflammatory fragment of alpha-MSH, taken at 200 to 500 mcg once or twice daily. It is used mainly for gut inflammation, where the PepT1 transporter carries it into inflamed intestinal cells.

A ready-mixed solution of the compound that carries fatty acids into mitochondria to be burned. Injected into muscle at 500 to 1,000 mg a few times a week for fat loss and performance, or under the skin at much smaller daily doses to build up muscle carnitine stores. Timing and whether you are fasted both change what it does.

A fat-dissolving solution injected directly into a marked grid of points over a fatty area, in a course of 3 to 5 sessions spaced exactly 7 days apart. Dosed by millilitres per injection point, not by weight. Most of the work is a preparation, sterility, and aftercare procedure.

Lipo-C with a stimulant added. A ready-mixed injection of ATP, Eria jarensis, L-carnitine, methionine, choline, and inositol, with lidocaine for comfort, given into muscle 2 to 5 days a week. Focused energy and mild to moderate appetite suppression, and a substantial interaction list to go with it.

The most aggressive product in the lipotropic line: fat metabolism support plus albuterol for stimulant energy and heat production. A ready-mixed injection given into muscle 2 to 5 days a week. Ingredients are declared; side effects and contraindications are not documented.

A ready-mixed lipotropic injection given into muscle, 2 to 5 days a week on an eight-week cycle. Only the schedule and the storage rule are established — there is no ingredient list, and no documented side effects or contraindications.

A ready-mixed injection of methionine, choline chloride, L-carnitine, and vitamin B5, given into muscle 2 to 5 days a week. Used to support fat metabolism, liver function, and energy. Must never be refrigerated — it crystallises.

A ready-mixed lipotropic injection given into muscle, 2 to 5 days a week on an eight-week cycle. Only the schedule and storage rule are established — there is no ingredient list, and no documented side effects or contraindications.

The body's own antimicrobial peptide, made by immune and skin cells. It punctures bacterial membranes, breaks up biofilms, neutralises endotoxin and steers the immune response toward balance. Human trials are topical wound-healing only; injectable use is extrapolated. Several autoimmune conditions rule it out.

A dual agonist of the GLP-1 and glucagon receptors, designed for Type-2 diabetes and obesity. Averaged 9.5% weight loss at 12 weeks and 14% at 48 weeks, and it is regarded as the safest of the GLP-1 peptides. Injected under the skin once a week.

A synthetic copy of alpha-MSH, the hormone that tells skin to make pigment. It produces a tan at far lower UV exposure than normal, suppresses appetite and raises sexual arousal. Dosed from a 10 mg vial: a 7 to 14 day loading phase at 0.25 to 0.5 mg daily, then 0.25 to 0.5 mg two to three times a week to hold the tan.

A synthetic compound on the World Health Organization's List of Essential Medicines, taken here as one 25 mg pill a day for mitochondrial and cognitive support. It carries a serious interaction risk: it blocks the enzyme MAO-A, so combining it with antidepressants or other serotonin-raising drugs can cause serotonin syndrome.

MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle after mechanical stress, where it activates satellite cells. Its 5 to 7 minute half-life means it must be injected intramuscularly into the trained muscle immediately post-workout.

One vial holding 5-Amino-1MQ 10 mg, MOTS-c 10 mg, and NAD+ 100 mg — three compounds that all act on how cells produce energy. Mixed with 3 mL of bacteriostatic water and injected under the skin at 50 units, two or three mornings a week.

An orally active, non-peptide ghrelin mimetic taken once daily at 10–25 mg. It stimulates the GHS-R1a receptor to raise growth hormone and IGF-1 across the whole day, with human trial data on fat-free mass, anti-catabolic effects, bone turnover and sleep.

A peptide your own mitochondria encode, released in response to exercise — which is why it is called an exercise mimetic. It improves how muscle handles glucose, which is linked to weight loss, better performance, less insulin resistance, and a long list of age-related conditions.

MT-1 (Melanotan 1, afamelanotide) is a selective MC1R agonist that stimulates eumelanin production for tanning and photoprotection, with 47% fewer sunburn cells in Phase 1 trials and FDA approval as the Scenesse 16 mg implant for erythropoietic protoporphyria since October 2019.

A chemically modified form of Semax delivered as a nasal spray, supplied as 10 mg in a 10 mL atomizer that dispenses 100 mcg per spray. Only handling and dosing data exist for this form, so the background below draws on the Semax entries on this site.

A coenzyme present in every living cell and central to energy production, DNA repair, and the body clock. Levels fall from around age 30 and may be down 50% or more by the 40s. Reconstituted with extra bacteriostatic water and injected under the skin or into muscle, in cycles.

The nasal spray form of NAD+, the coenzyme every cell needs for energy production and DNA repair, whose levels start falling around age 30 and may be down 50% or more by the 40s. Four to twenty sprays a day on two to six days a week, over an unusually long 12-week cycle with only a 2-week break.

A nasal spray combining NAD+, the coenzyme cells need for energy production, with two antioxidants — glutathione and vitamin C. Two to four sprays once or twice a day, every day, on a 12-week cycle with a 4-week break.

An oral GLP-1 receptor agonist taken as 6 mg pills once a day, titrated from a quarter pill up to six. It slows food leaving the stomach, increases fullness, raises insulin release and reduces glucagon. Unlike earlier oral GLP formulations it has no water-intake restrictions.

A nine-amino-acid hormone from the posterior pituitary, called the love or cuddle hormone for its role in trust, bonding, and desire. Studied for anxiety, mood, social and sexual function, orgasm quality, cortisol, pain, inflammation, heart health, addiction, blood sugar, and sleep.

The nine-amino-acid bonding hormone as a nasal spray (50 micrograms per spray), the route that reaches the brain for mood, stress and connection. Onset is 15 to 30 minutes, so it is taken 20 to 30 minutes before the moment it is wanted rather than on a fixed daily clock, typically at 20 to 40 IU.

A pancreas-derived tetrapeptide bioregulator studied for insulin secretion, glucose metabolism, and regeneration of pancreatic tissue. Injected under the skin daily or every other day, on cycles of 20 to 60 days.

PEG-MGF is the pegylated form of Mechano Growth Factor, an IGF-1Ec splice variant peptide used to activate muscle satellite cells. PEGylation extends its half-life from roughly 5 to 7 minutes to hours, but no published studies exist on PEG-MGF itself.

A synthetic tripeptide bioregulator (Glu-Asp-Arg) derived from pineal and cortical peptide complexes, studied for neuroprotection, cognition, circadian rhythm, and anti-ageing. Injected under the skin once daily in the morning on short 10- to 20-day cycles, two or three times a year.

A short peptide bioregulator for the prostate gland, aimed at benign prostatic hyperplasia, urinary flow, and male reproductive function. Injected under the skin daily for 30 to 60 days, three or four times a year.

A synthetic 7-amino-acid melanocortin receptor agonist for sexual dysfunction that works through the brain's MC4 receptors rather than blood flow, FDA approved in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Injected subcutaneously 45 to 60 minutes before sexual activity.

The same melanocortin-system peptide as the injectable, delivered as a nasal spray at 100 micrograms per spray. Taken 30 to 60 minutes before sexual activity to address persistently low sexual desire. No injection, and no capped maximum dose — but the same monthly limits.

A synthetic heptapeptide built from the immune peptide tuftsin, approved in Russia since 2009 as a nasal spray for generalised anxiety, reducing anxiety without sedation or dependency. Injectable route: reconstituted with bacteriostatic water, given as a small subcutaneous dose, usually 100 to 300 mcg daily.

The nasal form of Selank, a synthetic seven-amino-acid analogue of the immune peptide tuftsin, approved in Russia since 2009 as a nasal spray for generalised anxiety, with intranasal bioavailability of 92.8 per cent. Practical dosing is 200 to 400 mcg per administration, two to three times daily.

A synthetic ACTH-fragment peptide developed in Russia in 1982 and prescribed there for stroke, brain injury, cognitive decline, and optic nerve disease. It raises BDNF to support memory, focus, mood, and protection of brain tissue. Reconstituted with bacteriostatic water and injected under the skin.

The nasal spray form of Semax, a synthetic peptide derived from ACTH(4-10), developed in Russia in 1982 and studied for memory, focus, mood, and stroke recovery. Dosed in sprays rather than injections, with onset in about 15 to 30 minutes and effects lasting up to 24 hours.

A synthetic copy of the first 29 amino acids of growth hormone-releasing hormone. It signals the pituitary to release growth hormone in natural pulses, supporting sleep, recovery, lean mass and fat loss. Injected under the skin before bed, fasted.

A synthetic small molecule that activates the estrogen-related receptors (ERRα, ERRβ, ERRγ) and is marketed as an "exercise mimetic". Every published study injected it into mice in a DMSO-based vehicle; no human trial exists, and the compound does not dissolve in bacteriostatic water alone.

The capsule form of SLU-PP-332, a small molecule studied as an "exercise mimetic" that switches on some of the cellular machinery a workout does. Sold as 300 mcg and 1,000 mcg capsules taken fasted in the morning on a 4 to 8 week cycle, but no human dose exists and oral absorption is unproven.

A combination capsule pairing SLU-PP-332, an "exercise mimetic" that drives cells to build energy machinery, with 5-Amino-1MQ, an enzyme blocker that raises NAD+ and reduces fat mass. One capsule a day for two weeks, then two, taken fasted first thing in the morning.

A single capsule pairing 250 mcg of SLU-PP-332 with 50 mg of BAM-15 — an "exercise mimetic" that pushes cells to build energy machinery alongside an uncoupler that makes that machinery burn fuel off as heat. One or two pills a day, fasted, on a 4 to 6 week cycle, with hydration and electrolytes.

A single pill pairing 250 mcg of SLU-PP-332, an "exercise mimetic", with 6 mg of orforglipron, an oral GLP-1 receptor agonist that suppresses appetite. Every other day for the first week if you are new to GLP compounds, then daily, stepping up to two pills from week 11.

An eight-amino-acid peptide that relaxes the facial muscles responsible for expression lines, working on the same target as Botox but from the outside. A 10 mg vial is dissolved and stirred into up to an ounce of cream or serum, then applied morning and night.

A mitochondria-targeted antioxidant peptide that mops up free radicals and protects the machinery that makes cellular energy; billed as the most potent energy-boosting peptide available. Dosed at 1 to 2 mg daily for 4 to 8 weeks; older guidance ran fasted morning 8 to 12 week cycles by vial size.

50 to 75 units under the skin, two or three times a week, on a 4 to 6 week cycle. No ingredients, strength, vial size, benefits, or safety information of any kind have been published for this product.

A dual agonist of the GLP-1 and glucagon receptors, developed for Type-2 diabetes and obesity. Reached 19% total body weight loss at 4.8 mg weekly and has shown promise in fatty liver disease with moderate fibrosis. Injected under the skin once a week.

A synthetic form of thymosin beta-4 studied for wound healing, muscle, tendon and ligament repair, and reduced inflammation and scarring. Reconstituted with bacteriostatic water and injected under the skin, traditionally twice a week or daily at lower doses alongside BPC-157.

A stabilised GHRH analogue, approved in 2010 as Egrifta for HIV-associated lipodystrophy and dosed at 2 mg daily to reduce visceral and liver fat while preserving lean mass. Unusual handling: reconstituted vials are kept at room temperature, because refrigeration makes the solution gel.

A single vial holding 10 mg of Tesamorelin and 3 mg of Ipamorelin. Two peptides that raise the body's own growth hormone through different pathways, dosed once nightly on a long cycle. It needs acetic acid as well as bacteriostatic water to dissolve, and keeps only two weeks once mixed.

A triple monoamine reuptake inhibitor (SNDRI) that raises serotonin, noradrenaline and dopamine. Originally trialled for Parkinson's and Alzheimer's, now used as a potent oral appetite suppressant: 11.2% weight loss at 0.5 mg over 24 weeks. Long serotonergic interaction list and serotonin syndrome risk.

Thymalin is a complex of short thymic peptides, approved in Russia since 1982, given in 10-day courses of 10 mg daily once or twice a year to restore T cell, NK cell and B cell function. Long-term Russian studies report 2.0 to 2.1 fold lower mortality; a 2021 COVID-19 trial halved hospital deaths.

A 28-amino-acid thymic peptide that restores T-cell, natural killer and dendritic cell function, improves vaccine response and modulates inflammation. Approved in 35+ countries as thymalfasin; dosed 1.6 mg subcutaneously twice weekly, with a daily two-week variant sometimes used in acute infection.

A dipeptide isolated from the thymus gland, used for immune modulation, tissue regeneration, and cellular balance. Given as a 5 mg dose once a day for 10 days, three or four times a year, by injection under the skin or into muscle.

VIP is a 28-amino-acid signalling peptide the body makes throughout the brain, nerves, lungs, gut, and immune system, described as one of the strongest natural anti-inflammatory peptides.

Methylcobalamin, the active form of vitamin B12, as a ready-mixed injection. 5,000 micrograms once a week for four to ten weeks, then a maintenance dose once or twice a month, indefinitely. Given into muscle.